Completed PHASE1 INTERVENTIONAL 1-arm NCT01452425

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome.

Sponsor: Université Catholique de Louvain

Interventions EMG assessment INVOS assessment Tourniquet

Updated 7 times since 2017 Last updated: Dec 15, 2014 Started: Oct 31, 2011 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01452425, this PHASE1 trial focuses on Human Volunteers and remains completed. Sponsored by Université Catholique de Louvain, it has been updated 7 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Jan 2021 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Université Catholique de Louvain

Data source: Université Catholique de Louvain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium